Warm congratulations to Haibu Pharmaceutical for winning the Excellent Enterprise Award in the "T100 New Technology and New Product Innovation Action".

　　On April 23, 2019, the award ceremony for the "T100 New Technology and New Product Innovation Action" organized by the Beijing Municipal Science and Technology Commission and co-hosted by the Beijing Technology Collaboration Consulting Service Center, Beijing Technology Economic Information Joint Center, and Beijing International Science and Technology Service Center was held at the Sheraton Hotel in Yongtai, Beijing. Haibu Pharmaceutical Technology Co., Ltd. won the "Outstanding Enterprise Award" in this selection! Dr. Zhang Xu, the API R&D Director of Haibu Pharmaceutical, attended the event to accept the award and delivered a speech.

　　This award is another honor for Haibu Pharmaceutical following its recognition as one of the "Top 20 Chinese Pharmaceutical R&D Companies" by the All-China Federation of Industry and Commerce in 2017!

　　"T100 New Technology and New Product Innovation Action" aims to promote and implement the national innovation-driven development strategy and the construction of Beijing's National Science and Technology Innovation Center, grasping future technological development directions, showcasing capital's technological innovation achievements, expanding social influence of technology in changing lives, and promoting new technologies and new products.

　　The enterprises that are about to be awarded are all recognized for their new technologies and new products in the industry. Haibu Pharmaceutical's selection as an outstanding enterprise in the "T100 New Technology and New Product Innovation Action" is inseparable from its own efforts. In the future, Haibu Pharmaceutical will closely follow the trend of times with more rigorous and efficient R&D capabilities, further strengthen the application of innovative technologies, and return with even better results to customers! Give back to society!